Association of a polymorphic variant of the adiponectin gene with Insulin resistance in African Americans

Clinical and Translational Science

Volumn 1, Issue 3, 2008, Pages 194-199

  Specchia, Claudia ^a   Scott, Kathryn ^b   Fortina, Paolo ^b,c   Devoto, Marcella ^c,d   Falkner, Bonita ^e  

^a UNIVERSITY OF BRESCIA   (Italy)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Adiponectin; African Americans; Genetics; Insulin resistance

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHRONIC DISEASE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPONECTIN; ADULT; AFRICAN AMERICANS; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MOLECULAR WEIGHT; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77953394340     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2008.00055.x     Document Type: Article

References (34)

1. Reaven G. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
2. Meigs JB. Invited commentary: Insulin resistance syndrome?Syndrome X?Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol. 2000;152:908-911.
3. Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metob. 1998;83:2773-2776.
4. Reaven GM. The metabolic syndrome: Is this diagnosis necessary? Am J Clin Nutr. 2006;83:1237-1247.
5. Pittas AG, Joseph NA, Greenberg AS. Adipocytokines and insulin resistance. J Gin Endocrinol Metab. 2004;89:447-452.
6. Pickup JC, Chusney GD, Thomas SM, Burt D. Plasma interleukin-6, tumor necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci. 2000;67:291-300.
7. Haffner SM, Mykkanen L, Rainwater DL, Karhapaa P, Laakso M. Is leptin concentration associated with the insulin resistance syndrome in nondiabetic men? Obes Res. 1999;7:164-169.
8. Festa A, D'Agostino R Jr, Tracy RP, Haffner SM. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: The insulin resistance atherosclerosis study. Diabetes. 2002;51:1131-1137.
9. Winkler G, Salamon F, Salamon D, Speer G, Simon K, Cseh K. Elevated serum tumour necrosis factor-alpha levels can contribute to the insulin resistance in type II (non-insulin-dependent) diabetes and in obesity. Diabetologia. 1998;41:860-861.
10. Weyer C, Funahashi T Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Takaranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and Hyperinsulinemia. J Gin Endocrinol Metab. 2001;86:1930-1935.
11. Arita Y, Kihara S, Ouchi N, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79-83.
12. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamota Y, Ishigami M, Kuriyama H, Kishida K, Nishizawa H, Hotta K, Muraguchi M, Ohmoto Y, Yamashita S, Funahashi T, Matsuzawa Y Adipocyte-derived plasma protein, adiponectin, suppress lipid accumulation and class A receptor expression in human monocyte-derived macrophages. Grculation. 2001;103: 1057-1063
13. Okamoto Y, Arita Y, Nishida M, Maraguchi M, Ouchi N, Takahashi M, Igura T, Inui Y, Kihara S, Nakamura T, Yamashita S, Miyagawa J, Funahashi T, Matsuzawa Y An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res. 2000;32: 47-50
14. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y Novel modulator for endothelial adhesion molecules adipocyte-derived plasma protein adiponectin. Circulation. 1999;100:2473-2476
15. Goldstein BJ, Scalia R. Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab. 2004;89:2563-2568.
16. Gu HF, Abulaiti A, Ostenson C-G, Humphreys K, Wahlestedt C, Brookes AJ, Efendic S. Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish Caucasians. Diabetes. 2004;53(Suppl 1):S31-S35.
17. Menzaghi C, Ercolino T, Di Paola R, Berg AH, Warram JH, Scherer PE, Trischitta V, Doha A. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes. 2002;51:2306-2312
18. Parra EJ, Marcini A, Akey J, Martinson J, Batzer MA, Cooper R, Forrester T, Allison DB, Deka R, Ferrell RE, Shriver MD. Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet. 1998;63:1839-1851.
19. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
20. Rizza RA, Mandarino LJ, Gerich JE. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol. 1981;240:E630-E639.
21. Falkner B, Kushner H, Tulenko T, Sumner AE, Marsh JB. Insulin sensitivity, lipids, and blood pressure in young American blacks. Arterioscler Thromb Vase Biol. 1995;15vl798-15vl804.
22. 3. Clin Chem. 1984;30:839-842.
23. Friedewald WT, Levy Rl, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
24. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K, Kadowaki H, Hagura R, Akanuma Y, Yazaki Y, Nagai R, Taniyama M, Matsubara K, Yoda M, Nakano Y, Kimura S, Tomita M, Kimura S, Ito C, Froguel P, Kadowaki T. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002;51:536-540.
25. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, Fu Y, Motone M, Yamamoto K, Matsuo A, Ohashi K, Kihara S, Funahashi T, Rakugi H, Matsuzawa Y, Ogihara T. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension. 2004;43:1318-1323.
26. Heid IM, Wagner SA, Gohike H, Iglseder B, Mueller JC, Cip P, Ladurner G, Reiter R, Stadlmayr A, Mackevics V, Illig T, Kronenberg F, Paulweber B. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes. 2006;55:375-384.
27. Hu FB, Doria A, Li T, Meigs JB, Liu S, Memisoglu A, Hunter D, Manson JE. Genetic variation at the adiponectin locus and risk of type 2 diabetes in women. Diabetes. 2004;53:209-213.
28. Brown NJ, Murphey LJ, Srikuma N, Koschachuhanan N, Williams GH, Vaughan DE. Interactive effect of PAI-1, 4G/5G genotype and salt intake on PAI-1 antigen. Arteriosder Thromb Vase Biol. 2001;21:1071-1077
29. Weiss R, Dufour S, Groszmann A, Petersen K, Dziura J, Taksali SE, Shulman G, Caprio S. Low adiponectin levels in adolescent obesity: A marker of increased intramyoce11ular lipid accumulation. J Clin EndocrinolMetab. 2003;88:2014-2018.
30. Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, Okazaki Y, Ishii T, Nishikai K, Saruta T. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond). 2002;103:137-142.
31. Bottner A, Kratzsch J, Muller G, Kapellen TM, Bluher S, Keller E, Bluher M, Kiess W. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab. 2004;89:4053-4061.
32. Degawa-Yamauchi M, DiIts JR, Bovenkerk JE, Saha C, Pratt JH, Considine RV. Lower serum adiponectin levels in African-American boys. Obes Res. 2003;11:1384-1390.
33. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchannan TA, Scherer PE. Complex distribution, not absolute amount of adiponectin correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem. 2004;279:12152-12163.
34. Xu A, Chan KW, Hoo RLC, Wang Y, Tan KCB, Zhang J, Chen B, Lam MC, Tse C, Cooper GJS, Lam KSL. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem. 2005;280:18073-18080.